Enhancement of encapsulation efficiency of nanoemulsion-containing aripiprazole for the treatment of schizophrenia using mixture experimental design

Aripiprazole is considered as a third-generation antipsychotic drug with excellent therapeutic efficacy in controlling schizophrenia symptoms and was the first atypical anti-psychotic agent to be approved by the US Food and Drug Administration. Formulation of nanoemulsion-containing aripiprazole was...

Descripción completa

Detalles Bibliográficos
Autores principales: Fard Masoumi, Hamid Reza, Basri, Mahiran, Sarah Samiun, Wan, Izadiyan, Zahra, Lim, Chaw Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610787/
https://www.ncbi.nlm.nih.gov/pubmed/26508853
http://dx.doi.org/10.2147/IJN.S89364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610787/
https://www.ncbi.nlm.nih.gov/pubmed/26508853
http://dx.doi.org/10.2147/IJN.S89364

Ejemplares similares